Probity Advisors, Inc. Shockwave Medical, Inc. Transaction History

Probity Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$191.17 - $325.63 $5,543 - $9,443	29 Added 1.55%	1,902 $619,000
Q4 2023 Feb 12, 2024	BUY	$160.99 - $215.69 $7,405 - $9,921	46 Added 2.52%	1,873 $356,000
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $5,246 - $7,667	27 Added 1.5%	1,827 $363,000
Q2 2023 Aug 10, 2023	SELL	$223.05 - $302.68 $9,145 - $12,409	-41 Reduced 2.23%	1,800 $513,000
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $2,043 - $2,968	10 Added 0.55%	1,841 $378,000
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $4,489 - $7,142	-23 Reduced 1.24%	1,831 $509,000
Q2 2022 Aug 12, 2022	SELL	$115.91 - $214.48 $5,679 - $10,509	-49 Reduced 2.57%	1,854 $354,000
Q1 2022 May 10, 2022	SELL	$127.96 - $207.36 $383 - $622	-3 Reduced 0.16%	1,903 $395,000
Q4 2021 Feb 10, 2022	SELL	$165.13 - $241.83 $990 - $1,450	-6 Reduced 0.31%	1,906 $340,000
Q3 2021 Oct 08, 2021	BUY	$163.99 - $235.57 $3,115 - $4,475	19 Added 1.0%	1,912 $394,000
Q2 2021 Aug 06, 2021	SELL	$131.45 - $201.49 $8,281 - $12,693	-63 Reduced 3.22%	1,893 $359,000
Q1 2021 Apr 28, 2021	BUY	$92.73 - $142.05 $181,379 - $277,849	1,956 New	1,956 $255,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Probity Advisors, Inc. with notifications on news.